Treatment Advances in Chronic Lymphocytic Leukemia
Nicole Lamanna, MD, explains how chronic lymphocytic leukemia commonly presents in patients and discusses the significance of novel treatment approaches in transforming the way the condition is managed.
▼ Episode 1 CLL Versus Other Leukemia Types
Nicole Lamanna, MD, provides an overview of chronic lymphocytic leukemia and explains how it differs from other types of leukemia.
Nicole Lamanna, MD, explains what refractory disease in chronic lymphocytic leukemia means and remarks on the importance of clinical trials and the use of stem cell transplantation for appropriate patients in this setting.
► Episode 9 Why It's an Exciting Time for Patients With CLL
Nicole Lamanna, MD, reminds patients with chronic lymphocytic leukemia about current research efforts and new therapies that are helping to transform how CLL is managed. Additionally, Dr. Lamanna offers advice to newly diagnosed patients.
► Episode 11 CLL: An Early Clinical Trial With Ibrutinib
Brian Koffman, MDCM, MSEd, discusses his rejection of allogeneic stem cell transplant and development of chemorefractory chronic lymphocytic leukemia (CLL) that led to his participation in an early clinical trial of ibrutinib.
► Episode 12 CAR T-Cells: Refining CLL Therapy With Clinical Trials
Brian Koffman, MDCM, MSEd, shares insight on his current relapse of chronic lymphocytic leukemia (CLL) and discusses the potential value of chimeric antigen receptor (CAR) T-cell therapy, which he will be receiving in an upcoming clinical trial.
► Episode 14 Patient Perspectives on the CLL Treatment Paradigm
Brian Koffman, MDCM, MSEd, provides insight from a patient’s perspective on self-advocacy and reflects on the positive direction in which the treatment paradigm of chronic lymphocytic leukemia (CLL) is heading.